aap

Successful start in 2015 with 45% LOQTEQ® sales increase and 23% growth in biomaterials business

aap Implantate AG / aap: Successful start in 2015 with 45% LOQTEQ® sales increase and 23% growth in biomaterials business . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

aap Implantate AG (XETRA: AAQ.DE) made a successful start to financial year 2015 with significant sales growth. According to preliminary figures, sales increased in the first three months of this year compared to the corresponding period in the last year by 16% to EUR 7.1 million (Q1/2014: EUR 6.1 million). Thereby the company exceeded its guidance provided in February of EUR 6.5 million to EUR 7.0 million.

Sales in EUR million	Q1/2015	Q1/2014	Change on year
Trauma	2.5	2.2	15%
thereof LOQTEQ®	1.7	1.1	45%
Biomaterials	4.4	3.6	23%
Projects	0.1	0.1	109%
Other	0.1	0.2	-81%
Total sales	7.1	6.1	16%

The growth drivers of this positive sales performance in the first three months of the current financial year were the LOQTEQ® product family and the biomaterials business. aap Implantate AG significantly increased sales with the LOQTEQ® portfolio in the first quarter of 2015 year-on-year by 45% to EUR 1.7 million (Q1/2014: EUR 1.1 million). Performance in the reporting period testifies to the anatomic plate system continuing to establish itself in the market.